Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (201-210 of 391) with videos related to

Pageof 40
Sort By:
Annals of Neurology|July 18, 2018
Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Alison Goate, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersKellen K Petersen, Marta Milà-Alomà, Duygu Tosun, et al.
Annals of Clinical and Translational Neurology|March 28, 2023
Independent study demonstrates amyloid probability score accurately indicates amyloid pathologyIlana Fogelman, Tim West, Joel B Braunstein, et al.
Alzheimer'S Research & Therapy|April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairmentErica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2026
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in femalesCarling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Journal of Proteome Research|November 24, 2021
Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's DiseaseEvan E Hubbard, Lilian R Heil, Gennifer E Merrihew, et al.
Alzheimer'S Research & Therapy|July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutationsSimon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Acta Neuropathologica Communications|November 28, 2018
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's diseaseDaniel Twohig, Elena Rodriguez-Vieitez, Sigrid B Sando, et al.
Nature Aging|April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's diseaseNicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
JAMA Neurology|May 26, 2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer DiseaseGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Pageof 40

Showing results (201-210 of 391) with videos related to

Sort By:
Pageof 40
Annals of Neurology|July 18, 2018
Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Alison Goate, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersKellen K Petersen, Marta Milà-Alomà, Duygu Tosun, et al.
Annals of Clinical and Translational Neurology|March 28, 2023
Independent study demonstrates amyloid probability score accurately indicates amyloid pathologyIlana Fogelman, Tim West, Joel B Braunstein, et al.
Alzheimer'S Research & Therapy|April 10, 2026
Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairmentErica Andreozzi, Takuya Yagi, Kristin Wildsmith, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2026
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in femalesCarling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Journal of Proteome Research|November 24, 2021
Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's DiseaseEvan E Hubbard, Lilian R Heil, Gennifer E Merrihew, et al.
Alzheimer'S Research & Therapy|July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutationsSimon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Acta Neuropathologica Communications|November 28, 2018
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's diseaseDaniel Twohig, Elena Rodriguez-Vieitez, Sigrid B Sando, et al.
Nature Aging|April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's diseaseNicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
JAMA Neurology|May 26, 2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer DiseaseGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Pageof 40